These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1444095)
21. [Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)]. Loven JO; Brøndbo K; Ganes T Tidsskr Nor Laegeforen; 1993 Mar; 113(7):841-3. PubMed ID: 8480289 [TBL] [Abstract][Full Text] [Related]
22. [Indications for botulinum toxin in laryngectomy]. Klap P; Marion MH; Perrin A; Fresnel-Elbaz E; Cohen M Rev Laryngol Otol Rhinol (Bord); 1993; 114(4):281-7. PubMed ID: 8029549 [TBL] [Abstract][Full Text] [Related]
23. Physiologic assessment of botulinum toxin effects in the rat larynx. Inagi K; Connor NP; Ford CN; Schultz E; Rodriquez AA; Bless DM; Pasic T; Heisey DM Laryngoscope; 1998 Jul; 108(7):1048-54. PubMed ID: 9665255 [TBL] [Abstract][Full Text] [Related]
24. Spasmodic dysphonia and laryngeal botulinum toxin injection. Smith ME West J Med; 1993 Jul; 159(1):74. PubMed ID: 8351914 [No Abstract] [Full Text] [Related]
25. Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia. Hillel AD; Maronian NC; Waugh PF; Robinson L; Klotz DA Ann Otol Rhinol Laryngol; 2004 May; 113(5):341-8. PubMed ID: 15174759 [TBL] [Abstract][Full Text] [Related]
26. Histology of nerves and muscles in adductor spasmodic dysphonia. Chhetri DK; Blumin JH; Vinters HV; Berke GS Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):334-41. PubMed ID: 12731628 [TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin for relief of bilateral abductor paralysis of the larynx: histologic study in an animal model. Cohen SR; Thompson JW; Camilon FS Ann Otol Rhinol Laryngol; 1989 Mar; 98(3):213-6. PubMed ID: 2923396 [TBL] [Abstract][Full Text] [Related]
28. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia. Liu TC; Irish JC; Adams SG; Durkin LC; Hunt EJ J Otolaryngol; 1996 Apr; 25(2):66-74. PubMed ID: 8683655 [TBL] [Abstract][Full Text] [Related]
29. Bilateral thyroarytenoid denervation: a new treatment for laryngeal hyperadduction disorders studied in the canine. Sercarz JA; Berke GS; Ming Y; Rothschiller J; Graves MC Otolaryngol Head Neck Surg; 1992 Nov; 107(5):657-68. PubMed ID: 1437204 [TBL] [Abstract][Full Text] [Related]
30. Effects of botulinum toxin on pathophysiology in spasmodic dysphonia. Bielamowicz S; Ludlow CL Ann Otol Rhinol Laryngol; 2000 Feb; 109(2):194-203. PubMed ID: 10685573 [TBL] [Abstract][Full Text] [Related]
36. Longitudinal effects of Botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia: part II. Rubin AD; Wodchis WP; Spak C; Kileny PR; Hogikyan ND Arch Otolaryngol Head Neck Surg; 2004 Apr; 130(4):415-20. PubMed ID: 15096423 [TBL] [Abstract][Full Text] [Related]
37. Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic, and videoendoscopic findings. Zwirner P; Murry T; Swenson M; Woodson GE Laryngoscope; 1992 Apr; 102(4):400-6. PubMed ID: 1556889 [TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia. Blitzer A Otolaryngol Head Neck Surg; 2005 Dec; 133(6):836-8. PubMed ID: 16360499 [TBL] [Abstract][Full Text] [Related]
39. Management of supraglottic squeeze in adductor spasmodic dysphonia: a new technique. Young N; Blitzer A Laryngoscope; 2007 Nov; 117(11):2082-4. PubMed ID: 17828055 [TBL] [Abstract][Full Text] [Related]
40. Differences in botulinum toxin dosing between patients with adductor spasmodic dysphonia and essential voice tremor. Orbelo DM; Duffy JR; Hughes Borst BJ; Ekbom D; Maragos NE J Voice; 2014 Jan; 28(1):123-7. PubMed ID: 24080335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]